All News

December 1 is observed as World AIDS Day.

A study that evaluated a phase 3 monoclonal antibody treatment that targeted Alzheimer’s disease, solanezumab (Eli Lilly), did not meet its primary endpoint in the EXPEDITION3 clinical trial, according to a statement from the company.

One entrepreneurial student had his first experience with pharmacy in high school, is that where we should be starting?

New progress made towards the development of an HIV vaccine.

Etanercept found equally effective treating plaque psoriasis compared with Enbrel.

Variants of GAL are more common among women, which may explain the high prevalence of multiple sclerosis.

A novel drug used in combination with radiation found to be a more effective treatment for prostate cancer.

Eli Lilly will not continue development on solanezumab for patients with mild cognitive impairment from Alzheimer’s disease.

Tri-Coast Pharmacy is recalling various lots of products with sterility assurance concerns.

About 1 in 6 women diagnosed with breast cancer have a symptom other than a lump.

The rubella virus stays in the body of patients with severe deficiencies in their immune defenses, making them more susceptible to side effects.

According to the CDC, 82% of American adults take at least one medication and 29% take five or more.

New findings show that treatment with cabozantinib decreased mortality risk by 20% in patients with metastatic kidney cancer.

Increased levels of tumor-associated myeloid cells reduce cancer cell sensitivity to treatments.

Top news of the day from across the healthcare landscape.

Top news of the day from across the health care landscape.

Rapid reduction of rheumatoid arthritis symptoms rated as the most important factor in choosing a treatment.

Anti-vascular endothelial growth factor agents are the criterion standard for diabetic macular edema.

Broadly neutralizing antibodies (bNAbs) may hold the key to eliminating HIV-1.

Expanded indication for FluLaval Quadrivalent includes use in children aged 6 months and older.

Officials with GlaxoSmithKline have received approval from the FDA’s Center for Biologics Evaluation and Research to expand the indication for FluLaval Quadrivalent to include use in children aged 6 months and older.

Individuals living with HIV have approximately a 50-50 chance of developing depression, which can cause adverse outcomes such as accelerated disease progression, suppressed immune function, and medication nonadherence.

APhA recently released a video celebrating 20 years of promoting pharmacist as immunizers.

Effective pharmacy management is about learning to be a servant to others. All of the responsibilities of a pharmacy manager can be generally grouped under 4 focuses of service.

As a pharmacy student assessing career options, you may think that employment with one of the major chains is the best, or even the only, viable path.

A historic clinical trial testing the efficacy of an experimental HIV vaccine regimen gets underway this week in South Africa.

Nonadherence costs $564 billion in losses for pharmaceutical manufacturers worldwide.

Soliqua 100/33 is a combination treatment of Lantus and lixisenatide for the treatment of type 2 diabetes.

Patients with multiple comorbidities contribute to escalating health care spending.